首页> 外文期刊>Human Pathology >κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma
【24h】

κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma

机译:核中的κ-阿片受体是食管鳞状细胞癌的新预后因子

获取原文
获取原文并翻译 | 示例
       

摘要

Opioid receptors, members of the G-protein-coupled receptor superfamily, appear to be involved in cancer progression. However, the expression and significance of opioid receptors in esophageal squamous cell carcinoma (ESCC) remain unclear. In this study, we demonstrated by flow cytometry that μ, δ, and κ-opioid receptors (MOR, DOR, and KOR) are expressed to various degrees in ESCC cell lines. The KOR protein was further examined by several methods in ESCC cell lines and tissues. Immunocytochemical staining localized KOR to the cell membrane in KYSE180 cells and the nucleus in EC109 cells, whereas no signal or weak staining of the cytoplasm was observed in KYSE150 cells. The expression of KOR was confirmed in ESCC cells by Western blotting. Furthermore, immunohistochemistry staining showed that KOR was up-regulated in ESCC tissues compared with nontumorous esophageal epithelium (P =.004, χ2 test). Moreover, high nuclear KOR expression was significantly correlated with lymph node metastasis in 256 ESCC cases (R = 0.144; P =.030, Kendall τB test). Patients with high nuclear KOR expression in ESCC had a significantly poorer prognosis (P =.001, log-rank test). Multivariate Cox analysis revealed that KOR in the nucleus was an independent prognostic factor (hazard ratio, 1.789; 95% confidence interval, 1.177-2.720; P =.006). Our results suggest that KOR is involved in the carcinogenesis or progression of ESCC and that nuclear KOR may be indicative of prognosis.
机译:阿片受体,G蛋白偶联受体超家族的成员似乎参与了癌症进展。然而,阿片类受体在食管鳞状细胞癌(ESCC)中的表达和意义仍不清楚。在该研究中,我们通过流式细胞术说明了μ,δ和κ-阿片受体(Mor,Dor和Kor)在ESCC细胞系中表达到各种程度。通过ESCC细胞系和组织中的几种方法进一步检查KOL蛋白。免疫细胞化学染色在Kyse180细胞中局部kor局部核对细胞膜和EC109细胞中的细胞核,而在Kyse150细胞中没有观察到细胞质的信号或弱染色。 KOL的表达通过Western印迹在ESCC细胞中证实。此外,免疫组织化学染色表明,与无紫外食管上皮(P = .004,χ2检验)相比,kor在ESCC组织中上调。此外,在256例ESCC病例中,高核Kner表达与淋巴结转移显着相关(r = 0.144; p = .030,kendallτb测试)。 ESCC高核Kor的患者的表达明显差,预后显着较差(P = .001,对数级测试)。多变量Cox分析显示,核中kor是独立的预后因子(危险比,1.789; 95%置信区间,1.177-2.720; p = .006)。我们的研究结果表明,kor参与了ESCC的致癌或进展,核群体可能表明预后。

著录项

  • 来源
    《Human Pathology》 |2013年第9期|共10页
  • 作者单位

    Institute of Oncologic Pathology Medical College of Shantou University No 22 Xinling Rd Shantou;

    Institute of Oncologic Pathology Medical College of Shantou University No 22 Xinling Rd Shantou;

    Institute of Oncologic Pathology Medical College of Shantou University No 22 Xinling Rd Shantou;

    Institute of Oncologic Pathology Medical College of Shantou University No 22 Xinling Rd Shantou;

    Department of Biochemistry and Molecular Biology Medical College of Shantou University Shantou;

    Institute of Oncologic Pathology Medical College of Shantou University No 22 Xinling Rd Shantou;

    Department of Oncology Surgery Shantou Central Hospital Affiliated Shantou Hospital of Sun Yat;

    Department of Pathology Shantou Central Hospital Affiliated Shantou Hospital of Sun Yat-Sen;

    Department of Biochemistry and Molecular Biology Medical College of Shantou University Shantou;

    Institute of Oncologic Pathology Medical College of Shantou University No 22 Xinling Rd Shantou;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

    κ-Opioid receptor; ESCC; GPCRs; Survival;

    机译:κ-阿片受体;ESCC;GPCRS;生存;
  • 入库时间 2022-08-20 08:10:56

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号